Global Asthma Inhaler Device Market, By Type (Metered Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers), Mode of Operation (Manually Operated Inhaler Devices, Digitally-Operated Inhaler Devices), End User (Hospitals & Clinics, Homecare, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Asthma Inhaler Device Market
The asthma inhaler device market is expected to witness market growth at a rate of 4.11% in the forecast period of 2021 to 2028 and is expected to reach USD 19,395.30 million by 2028. Data Bridge Market Research report on asthma inhaler device market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the prevalence of asthma globally is escalating the growth of asthma inhaler device market.
Asthma is defined as the chronic respiratory disease that blocks the airways of lung due to the mucus production, tightening of muscles and inflammation. An inhaler is referred as a device holding a medicine that the patient takes by breathing in (inhaling). Various types of inhalers are available in the market such as reliever inhalers and preventive inhalers among others.
The increasing incidences of the chronic respiratory disorder known as cancer across the globe acts as one of the major factors driving the growth of asthma inhaler device market. The increasing mortality rate due to the respective disease and the initiatives taken by government and NGOs for the growth of awareness regarding the respiratory disease accelerate the asthma inhaler device market growth. The rise in the need for rescue medication, availability of various product types and increasing demand for metered-dose inhalers further influences the asthma inhaler device market. Additionally, the growing geriatric population, increasing awareness regarding various respiratory diseases, rise in disposable income of people, research and development activities and surge in healthcare expenditure positively affect the asthma inhaler device market. Furthermore, drug launches and technological advancement extend profitable opportunities to the asthma inhaler device market players in the forecast period of 2021 to 2028.
On the other hand, the issues with the high pharyngeal deposition and difficulties in determining remaining doses are the factors expected to obstruct the asthma inhaler device market growth. The negative impact of COVID-19 on the manufacturing and pharmaceutical sectors is projected to challenge the asthma inhaler device market in the forecast period of 2021-2028.
This asthma inhaler device market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on asthma inhaler device market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Asthma Inhaler Device Market Scope and Market Size
The asthma inhaler device market is segmented on the basis of type, mode of operation and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the asthma inhaler device market is segmented into the metered-dose inhaler, dry powder inhaler and soft mist inhaler. The metered-dose inhaler is further segmented into standard pressurized metered-dose inhalers, breath-actuated pressurized metered-dose inhalers and metered-dose inhaler with a spacer.
- On the basis of mode of operation, the asthma inhaler device market is segmented into manually operated inhaler devices and digitally-operated inhaler devices.
- On the basis of end user, the asthma inhaler device market is segmented into hospitals & clinics, homecare and others.
Global Asthma Inhaler Device Market Country Level Analysis
The asthma inhaler device market is analyzed and market size insights and trends are provided by country, type, mode of operation and end user as referenced above.
The countries covered in the asthma inhaler device market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the asthma inhaler device market because of the increase in the incidence of asthma, demand for advanced technologies and high demand for metered-dose inhalers in the region. Europe is expected to be the second largest market owning to the initiatives by healthcare authorities to raise the awareness about asthma. Asia-Pacific is estimated to witness the fastest growth in the forecast period of 2021-2028 due to the presence of rapidly developing economies of China, India and South Korea and high prevalence of asthma among other respiratory diseases in the region.
The country section of the asthma inhaler device market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The asthma inhaler device market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for asthma inhaler device market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the asthma inhaler device market. The data is available for historic period 2011-2019.
Competitive Landscape and Asthma Inhaler Device Market Share Analysis
The asthma inhaler device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to asthma inhaler device market.
The major players covered in the asthma inhaler device market report are Koninklijke Philips N.V., GlaxoSmithKline plc, AstraZeneca, Cipla, Boehringer Ingelheim International GmbH, Beximco Pharmaceuticals Ltd., Merck Sharp & Dohme Corp., Teva Pharmaceutical Industries Ltd, CHIESI Farmaceutici S.p.A., Lifescience Pvt. Ltd, Medical Depot, Inc., HEALTH PRODUCTS, INC., Invacare Corporation, Omron Healthcare, Inc., PARI GmbH among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
